D'Alonzo Michele, Di Bacco Lorenzo, Fiore Antonio, Baudo Massimo, Zanin Francesca, Baldelli Chiara, Moini Cyrus, Folliguet Thierry, Muneretto Claudio
Cardiac Surgery Unit, University of Brescia, "Spedali Civili" Hospital, 25124 Brescia, Italy.
Cardiac Surgery Unit, Hôpital "Henri Mondor-Assistance Publique Hôpîtaux de Paris", 94100 Créteil, France.
J Cardiovasc Dev Dis. 2025 Apr 11;12(4):153. doi: 10.3390/jcdd12040153.
Acute aortic valve infective endocarditis (IE) presents a critical surgical timing dilemma. This study investigates whether early surgical intervention (within seven days of targeted antibiotic therapy initiation) affects mortality and clinical outcomes compared to delayed/conventional surgery.
A retrospective, multicenter analysis of 204 patients with aortic IE was conducted, excluding emergency cases requiring immediate intervention. Patients were stratified into EARLY (≤7 days) and LATE (>7 days) surgical groups. Primary endpoints included in-hospital mortality and major adverse events, while secondary endpoints assessed long-term survival, recurrence, and reintervention rates.
No significant differences in in-hospital mortality were observed between groups (16% in both). The LATE group exhibited a trend toward increased permanent pacemaker implantation (16% vs. 8.2%; = 0.100) and a higher incidence of postoperative atrial fibrillation (36% vs. 24%, = 0.048). Infective endocarditis recurrence and long-term survival did not significantly differ between groups. Predictors of one-year mortality included chronic kidney disease, annular abscess, extracorporeal membrane oxygenation (ECMO) use, and prolonged mechanical ventilation.
These findings suggest that early surgery, following a short course of antibiotics, does not compromise outcomes nor increase recurrence risk, challenging the conventional preference for delayed intervention in non-emergency IE cases.
急性主动脉瓣感染性心内膜炎(IE)存在关键的手术时机困境。本研究调查与延迟/传统手术相比,早期手术干预(在开始靶向抗生素治疗的七天内)是否会影响死亡率和临床结局。
对204例主动脉IE患者进行回顾性多中心分析,排除需要立即干预的急诊病例。患者被分为早期(≤7天)和晚期(>7天)手术组。主要终点包括住院死亡率和主要不良事件,而次要终点评估长期生存率、复发率和再次干预率。
两组之间住院死亡率无显著差异(均为16%)。晚期组在永久性起搏器植入方面有增加趋势(16%对8.2%;P = 0.100),术后房颤发生率更高(36%对24%,P = 0.048)。两组之间感染性心内膜炎复发率和长期生存率无显著差异。一年死亡率的预测因素包括慢性肾脏病、瓣周脓肿、体外膜肺氧合(ECMO)使用和机械通气时间延长。
这些发现表明,在短期抗生素治疗后进行早期手术,不会影响结局,也不会增加复发风险,这对非急诊IE病例延迟干预的传统偏好提出了挑战。